NCT00706342View on ClinicalTrials.gov

Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Purpura, Thrombocytopenic, Idiopathic
Interventions
DRUG

Fostamatinib Disodium / R935788

R935788 tablets

Trial Locations (2)

10065

Research Site, New York

44195

Research Site, Cleveland

Sponsors
All Listed Sponsors
lead

Rigel Pharmaceuticals

INDUSTRY